(Click for table) Current outbreaks in the WHO Eastern Mediterranean Region
Table last updated on 27 January 2024. For updates on coronavirus diseases 2019 (COVID-19), please check the regional and global dashboards.
| Countries | Diseases | Cumulative figures | Event date | ||
| Cases | Deaths | CFR% | |||
| Afghanistan | Acute watery diarrhoea (AWD) | 230651 | 109 | 0.05% | January-23 |
| Iraq* | Cholera | 1332 | 7 | 0.53% | August-23 |
| Somalia | Cholera | 20101 | 65 | 0.32% | January-23 |
| Sudan | Cholera | 10413 | 291 | 2.79% | June-23 |
| Syrian Arab Republic* | Cholera | 180288 | 7 | 0.00% | June-23 |
| Yemen | Cholera | 4066 | 15 | 0.37% | January-23 |
| Pakistan* | Cholera | 200 | 0 | 0.00% | January-23 |
| Afghanistan | Crimean-Congo haemorrhagic fever (CCHF) | 1264 | 114 | 9.02% | January-23 |
| Iraq | Crimean-Congo haemorrhagic fever (CCHF) | 2219 | 145 | 6.53% | January-23 |
| Pakistan* | Crimean-Congo haemorrhagic fever (CCHF) | 109 | 30 | 27.52% | January-23 |
| Pakistan* | Dengue Fever | 24352 | 0 | 0.00% | May-23 |
| Oman* | Dengue Fever | 2016 | 0 | 0.00.% | January-23 |
| Sudan | Dengue Fever | 10412 | 66 | 0.63% | January-23 |
| Yemen | Dengue Fever | 951 | 1 | 0.11% | January-24 |
| Afghanistan | Dengue Fever | 1700 | 1 | 0.06% | January-23 |
| Somalia* | Dengue Fever | 755 | 1 | 0.13% | September-23 |
| Saudi Arabia* | Dengue Fever | 2259 | 0 | 0.00% | March-23 |
| Pakistan* | Diphtheria | 611 | 55 | 9.00% | January-23 |
| Yemen* | Diphtheria | 128 | 1 | 0.78% | January-24 |
| Pakistan* | Human immunodeficiency virus (HIV) | 192 | 2 | 1.04% | January-22 |
| Egypt* | Legionnaires’ disease | 2 | 0 | 0.00% | September-23 |
| Morocco* | Legionnaires’ disease | 2 | 0 | 0.00% | October-23 |
| United Arab Emirates* | Legionnaires’ disease | 3 | 0 | 0.00% | March-23 |
| Djibouti* | Malaria | 25078 | 0 | 0.00% | January-23 |
| Islamic Republic of Iran* | Malaria | 5788 | 0 | 0.00% | January-23 |
| Pakistan* | Malaria | 4038328 | 0 | 0.00% | January-23 |
| Sudan* | Malaria | 924122 | 100 | 0.01% | April-23 |
| Afghanistan* | Malaria | 1609 | 0 | 0.00% | July-23 |
| Afghanistan | Measles | 28633 | 71 | 0.25% | January-23 |
| Djibouti* | Measles | 106 | 0 | 0.00% | January-23 |
| Islamic Republic of Iran* | Measles | 3675 | 0 | 0.00% | January-23 |
| Iraq* | Measles | 2000 | 0 | 0.00% | January-23 |
| Jordan* | Measles | 51 | 0 | 0.00% | April-23 |
| Lebanon* | Measles | 313 | 0 | 0.00% | January-23 |
| Libya* | Measles | 1142 | 0 | 0.00% | January-23 |
| Morocco* | Measles | 83 | 0 | 0.00% | November-23 |
| Pakistan* | Measles | 20736 | 0 | 0.00% | January-23 |
| Somalia | Measles | 14155 | 0 | 0.00% | January-23 |
| Sudan* | Measles | 4334 | 127 | 2.93% | April-23 |
| Northwest Syria* | Measles | 6584 | 0 | 0.00% | January-23 |
| Yemen | Measles | 21961 | 278 | 1.27% | January-23 |
| Saudi Arabia* | Middle East respiratory syndrome (MERS) | 5 | 3 | 60.00% | January-23 |
| United Arab Emirates* | Middle East respiratory syndrome (MERS) | 1 | 0 | 0.00% | July-23 |
| Bahrain* | Mpox | 2 | 0 | 0.00% | September-22 |
| Egypt* | Mpox | 3 | 0 | 0.00% | September-22 |
| Islamic Republic of Iran* | Mpox | 1 | 0 | 0.00% | August-22 |
| Jordan* | Mpox | 1 | 0 | 0.00% | September-22 |
| Lebanon* | Mpox | 27 | 0 | 0.00% | June-22 |
| Morocco* | Mpox | 3 | 0 | 0.00% | June-22 |
| Oman* | Mpox | 3 | 0 | 0.00% | October-23 |
| Pakistan* | Mpox | 7 | 0 | 0.00% | April-23 |
| Qatar* | Mpox | 5 | 0 | 0.00% | July-22 |
| Saudi Arabia* | Mpox | 8 | 0 | 0.00% | July-22 |
| Sudan* | Mpox | 19 | 1 | 5.26% | August-22 |
| United Arab Emirates* | Mpox | 16 | 0 | 0.00% | May-22 |
| Afghanistan | Poliomyelitis (Wild Polio 1) | 6 | 0 | 0.00% | May-23 |
| Pakistan | Poliomyelitis (Wild Polio 1) | 6 | 0 | 0.00% | February-23 |
| Afghanistan | Circulating vaccine-derived polioviruses (cVDPV2) | 43 | 0 | 0.00% | February-22 |
| Pakistan | Circulating vaccine-derived polioviruses (cVDPV2) | 8 | 0 | 0.00% | January-21 |
| Sudan | Circulating vaccine-derived polioviruses (cVDPV2) | 1 | 0 | 0.00% | October-22 |
| Somalia | Circulating vaccine-derived polioviruses (cVDPV2) | 5 | 0 | 0.00% | January-23 |
| Yemen | Circulating vaccine-derived polioviruses (cVDPV2) | 3 | 0 | 0.00% | August-23 |
| Syrian Arab Republic* | Hepatitis A | 4619 | 0 | 0.00% | July-23 |
* No update received from this country during the reporting period
